February 23, 2026 Experience Averin Capital Acquisition $250 million IPO We advised the underwriters on the IPO
February 20, 2026 Experience Marsh $600 million senior notes offering We advised Marsh on its investment-grade notes offering
February 20, 2026 Experience PG&E $1 billion fixed-to-fixed reset rate junior subordinated notes offering We advised the representatives of the underwriters on the offering
February 20, 2026 Experience Figure Technology Solutions first blockchain-native common equity offering registered with the SEC We advised Figure on the offering
February 20, 2026 Experience Amgen $4 billion notes offering We advised the bookrunners on the offering
February 20, 2026 Experience PGE $550 million stock offering and forward sale agreement We advised the underwriters, forward sellers and forward purchasers on the first utilities sector follow-on of 2026
February 19, 2026 Experience Coloplast acquisition of Uromedica We are advising Coloplast on the transaction
February 18, 2026 Experience PGE $500 million at-the-market offering We advised the sales agents and forward purchasers on the offering
February 18, 2026 Experience BioMarin Pharmaceutical $850 million debut senior notes offering We advised the representative of the initial purchasers
February 18, 2026 Experience Vestwell Holdings $385 million Series E funding round We advised Vestwell on the financing